Clinical Relevance of Mismatch Repair in Ovarian Cancer

卵巢癌错配修复的临床意义

基本信息

  • 批准号:
    7033262
  • 负责人:
  • 金额:
    $ 13.27万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-09-15 至 2011-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): A 5-year program integrating research, education, and teaching will provide the applicant with an excellent opportunity for the acquisition and refinement of skills in research methods that include design, conduct and analysis of high-quality epidemiologically-based cancer genetics research, under expert guidance of scientists in the field. Specific areas of focus for didactic training will be: 1) genetic epidemiology, 2) study design and statistical methodology, 3) laboratory-based molecular analyses, and 4) ovarian tumor biology, with the goal of applying this knowledge in translational research. The training and research objectives will be accomplished through formal training (course work), mentorship (through mentors/consultants who are experts in genetic epidemiology, statistics, molecular genetics and ovarian tumorigenesis), and practical experience (through conducting proposed research study). This particular project will address all learning objectives of the applicant through the various components of molecular, pathological and statistical analyses, and will provide her with the practical experience in these specific areas outlined. Through the provision of meaningful scientific data, the project itself will augment existing research associated with the genetics of ovarian cancer susceptibility with laboratory markers. It will build upon current knowledge in deciphering etiology and predicting prognosis and treatment response as it relates to the mismatch repair pathway to ovarian tumorigenesis, and form the basis of further translational studies. Dr. Pal's long-term goal is to develop a program of research in epidemiologically-based cancer genetics research utilizing an interdisciplinary approach. This goal will be accomplished by being in a faculty role at an academic health science center. The resources of the sponsoring institution are excellent and will facilitate the successful, efficient completion of the overall objectives outlined. The achievement of these goals will provide the expertise needed for a career as a successful, independent investigator committed to academic research.
描述(由申请人提供):一个为期5年的计划,整合研究,教育和教学将为申请人提供一个极好的机会,获得和完善研究方法的技能,包括设计,进行和分析高质量的流行病学为基础的癌症遗传学研究,在该领域科学家的专家指导下。重点教学培训的具体领域将是:1)遗传流行病学,2)研究设计和统计方法,3)基于实验室的分子分析,以及4)卵巢肿瘤生物学,目的是将这些知识应用于转化研究。培训和研究目标将通过正式培训(课程工作),导师(通过遗传流行病学,统计学,分子遗传学和卵巢肿瘤发生方面的专家导师/顾问)和实践经验(通过进行拟议的研究)来实现。这个特别的项目将通过分子,病理和统计分析的各个组成部分解决申请人的所有学习目标,并将为她提供在这些特定领域概述的实践经验。通过提供有意义的科学数据,该项目本身将增加与实验室标记物卵巢癌易感性遗传学相关的现有研究。它将建立在目前的知识,在破译病因和预测预后和治疗反应,因为它涉及到卵巢肿瘤发生的错配修复途径,并形成进一步的转化研究的基础。博士的长期目标是利用跨学科的方法开发一个基于流行病学的癌症遗传学研究计划。这一目标将通过在学术健康科学中心的教师角色来实现。赞助机构的资源是极好的,将有助于成功、有效地完成概述的总体目标。这些目标的实现将提供职业生涯所需的专业知识,作为一个成功的,独立的调查致力于学术研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Tuya Pal其他文献

Tuya Pal的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Tuya Pal', 18)}}的其他基金

Breast Cancer In Blacks: Impact of Genomics, Healthcare Use and Lifestyle on Outcomes (BRIGHT)
黑人乳腺癌:基因组学、医疗保健使用和生活方式对结果的影响 (BRIGHT)
  • 批准号:
    10194397
  • 财政年份:
    2017
  • 资助金额:
    $ 13.27万
  • 项目类别:
Breast Cancer In Blacks: Impact of Genomics, Healthcare Use and Lifestyle on Outcomes (BRIGHT)
黑人乳腺癌:基因组学、医疗保健使用和生活方式对结果的影响 (BRIGHT)
  • 批准号:
    9301180
  • 财政年份:
    2017
  • 资助金额:
    $ 13.27万
  • 项目类别:
(2/3) MMC, VICC, and TSU: Partners in Eliminating Cancer Disparities
(2/3) MMC、VICC 和 TSU:消除癌症差异的合作伙伴
  • 批准号:
    10328032
  • 财政年份:
    2011
  • 资助金额:
    $ 13.27万
  • 项目类别:
(2/3) MMC, VICC, and TSU: Partners in Eliminating Cancer Disparities
(2/3) MMC、VICC 和 TSU:消除癌症差异的合作伙伴
  • 批准号:
    10693353
  • 财政年份:
    2011
  • 资助金额:
    $ 13.27万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10693354
  • 财政年份:
    2011
  • 资助金额:
    $ 13.27万
  • 项目类别:
MMC, VICC, & TSU: PARTNERS IN ELIMINATING CANCER DISPARITIES (2 of 3)
MMC、VICC、
  • 批准号:
    9767522
  • 财政年份:
    2011
  • 资助金额:
    $ 13.27万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10328033
  • 财政年份:
    2011
  • 资助金额:
    $ 13.27万
  • 项目类别:
Clinical Relevance of Mismatch Repair in Ovarian Cancer
卵巢癌错配修复的临床意义
  • 批准号:
    7496110
  • 财政年份:
    2006
  • 资助金额:
    $ 13.27万
  • 项目类别:
Clinical Relevance of Mismatch Repair in Ovarian Cancer
卵巢癌错配修复的临床意义
  • 批准号:
    7286696
  • 财政年份:
    2006
  • 资助金额:
    $ 13.27万
  • 项目类别:
Clinical Relevance of Mismatch Repair in Ovarian Cancer
卵巢癌错配修复的临床意义
  • 批准号:
    7919385
  • 财政年份:
    2006
  • 资助金额:
    $ 13.27万
  • 项目类别:

相似海外基金

The mechanism of oral carcinogenesis by FAT1 gene mutation
FAT1基因突变导致口腔癌的机制
  • 批准号:
    23K15977
  • 财政年份:
    2023
  • 资助金额:
    $ 13.27万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of an efficient method combining quantum chemistry and machine learning to evolve PCR technology and gene mutation analysis
开发一种结合量子化学和机器学习的有效方法来发展 PCR 技术和基因突变分析
  • 批准号:
    22KJ2450
  • 财政年份:
    2023
  • 资助金额:
    $ 13.27万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Development of preemptive medicine for asymptomatic MEN1 gene mutation carriers
无症状MEN1基因突变携带者的抢先治疗药物开发
  • 批准号:
    23H03151
  • 财政年份:
    2023
  • 资助金额:
    $ 13.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Elucidation of molecular mechanisms of occurrence of anaplastic thyroid cancer using gene mutation analysis and comprehensive gene expression analysis
利用基因突变分析和综合基因表达分析阐明甲状腺未分化癌发生的分子机制
  • 批准号:
    23K08067
  • 财政年份:
    2023
  • 资助金额:
    $ 13.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of the molecular mechanism of maxillofacial hypoplasia caused by FAT1 gene mutation
FAT1基因突变引起颌面发育不全的分子机制阐明
  • 批准号:
    22K19629
  • 财政年份:
    2022
  • 资助金额:
    $ 13.27万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Association between CD79B gene mutation and prognosis in vitreoretinal lymphoma
CD79B基因突变与玻璃体视网膜淋巴瘤预后的关系
  • 批准号:
    22K09763
  • 财政年份:
    2022
  • 资助金额:
    $ 13.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Gene mutation/expression prediction from clinical images using artificial intelligence technology in pancreatic cancer
利用人工智能技术从临床图像预测胰腺癌基因突变/表达
  • 批准号:
    20K17570
  • 财政年份:
    2020
  • 资助金额:
    $ 13.27万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of colorectal carcinogenesis mediated by PTPRK gene mutation
PTPRK基因突变介导的结直肠癌发生机制的阐明
  • 批准号:
    20K16311
  • 财政年份:
    2020
  • 资助金额:
    $ 13.27万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the molecular mechanism of development of anaplastic thyroid cancer using gene mutation analysis and comprehensive gene expression analysis
利用基因突变分析和综合基因表达分析阐明甲状腺未分化癌发生的分子机制
  • 批准号:
    20K08953
  • 财政年份:
    2020
  • 资助金额:
    $ 13.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of next-generation precision medicine targeting the pathways on which driver gene mutation-positive lung cancer depends
针对驱动基因突变阳性肺癌所依赖的途径开发下一代精准医疗
  • 批准号:
    20H03771
  • 财政年份:
    2020
  • 资助金额:
    $ 13.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了